Free Trial

Ameriprise Financial Inc. Sells 35,427 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Addus HomeCare logo with Medical background

Ameriprise Financial Inc. cut its position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 22.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 120,040 shares of the company's stock after selling 35,427 shares during the period. Ameriprise Financial Inc. owned 0.66% of Addus HomeCare worth $15,047,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the stock. Lido Advisors LLC lifted its position in shares of Addus HomeCare by 60.7% during the fourth quarter. Lido Advisors LLC now owns 2,671 shares of the company's stock worth $335,000 after purchasing an additional 1,009 shares in the last quarter. Northern Trust Corp raised its holdings in Addus HomeCare by 3.3% in the fourth quarter. Northern Trust Corp now owns 285,872 shares of the company's stock worth $35,834,000 after purchasing an additional 9,122 shares during the period. Susquehanna Fundamental Investments LLC acquired a new stake in Addus HomeCare in the fourth quarter worth $1,716,000. Nebula Research & Development LLC raised its holdings in Addus HomeCare by 90.5% in the fourth quarter. Nebula Research & Development LLC now owns 14,225 shares of the company's stock worth $1,783,000 after purchasing an additional 6,757 shares during the period. Finally, Oberweis Asset Management Inc. raised its holdings in Addus HomeCare by 23.5% in the fourth quarter. Oberweis Asset Management Inc. now owns 59,900 shares of the company's stock worth $7,508,000 after purchasing an additional 11,400 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have recently issued reports on ADUS. Stephens reissued an "overweight" rating and set a $142.00 price objective on shares of Addus HomeCare in a research report on Wednesday, March 12th. Wall Street Zen downgraded shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Oppenheimer lifted their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Macquarie raised their target price on shares of Addus HomeCare from $129.00 to $133.00 and gave the stock an "outperform" rating in a research note on Thursday, May 8th. Finally, JMP Securities restated a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a research note on Tuesday, April 22nd. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Buy" and an average target price of $142.57.

Check Out Our Latest Research Report on ADUS

Addus HomeCare Stock Up 0.6%

Shares of NASDAQ:ADUS traded up $0.63 during midday trading on Friday, hitting $112.16. The stock had a trading volume of 181,565 shares, compared to its average volume of 167,317. The company's 50-day moving average price is $102.28 and its 200-day moving average price is $113.32. The company has a market capitalization of $2.06 billion, a P/E ratio of 25.67, a price-to-earnings-growth ratio of 1.41 and a beta of 0.85. Addus HomeCare Co. has a fifty-two week low of $88.96 and a fifty-two week high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, beating the consensus estimate of $1.33 by $0.09. The company had revenue of $337.71 million during the quarter, compared to analysts' expectations of $341.66 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business's revenue for the quarter was up 20.3% compared to the same quarter last year. During the same period in the previous year, the company earned $1.21 EPS. Research analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

About Addus HomeCare

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines